In addition, our findings are all in line with recently published work from Liu et al., which nicely demonstrated that genetically driven NAFLD is a causal risk factor for T2D but with a unique phenotype characterized as normal insulin sensitivity that is further associated with reduced insulin secretion, thus likely representing a late-onset type I-like diabetic phenotype. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.